Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
4616 | 1755 | 48.2 | 89% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
230 | 3 | P GLYCOPROTEIN//FMO3//TRIMETHYLAMINURIA | 49374 |
747 | 2 | P GLYCOPROTEIN//MULTIDRUG RESISTANCE//MDR1 | 12474 |
4616 | 1 | MRP1//MULTIDRUG RESISTANCE ASSOCIATED PROTEIN//MULTIDRUG RESISTANCE PROTEIN | 1755 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | MRP1 | authKW | 675495 | 6% | 35% | 112 |
2 | MULTIDRUG RESISTANCE ASSOCIATED PROTEIN | authKW | 463863 | 5% | 30% | 89 |
3 | MULTIDRUG RESISTANCE PROTEIN | authKW | 421343 | 4% | 34% | 72 |
4 | MRP | authKW | 312027 | 5% | 19% | 93 |
5 | MRP2 | authKW | 278815 | 4% | 24% | 67 |
6 | DUBIN JOHNSON SYNDROME | authKW | 258805 | 2% | 55% | 27 |
7 | TUMOR BIOCHEM | address | 196215 | 2% | 28% | 41 |
8 | CANC S | address | 171299 | 3% | 18% | 54 |
9 | MRP4 | authKW | 164716 | 1% | 38% | 25 |
10 | ABCC2 | authKW | 157608 | 2% | 28% | 32 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Pharmacology & Pharmacy | 4142 | 30% | 0% | 520 |
2 | Oncology | 3066 | 23% | 0% | 403 |
3 | Biochemistry & Molecular Biology | 1246 | 25% | 0% | 444 |
4 | Biophysics | 506 | 7% | 0% | 126 |
5 | Gastroenterology & Hepatology | 344 | 5% | 0% | 88 |
6 | Toxicology | 336 | 5% | 0% | 86 |
7 | Cell Biology | 214 | 8% | 0% | 135 |
8 | Medicine, Research & Experimental | 101 | 4% | 0% | 71 |
9 | Chemistry, Medicinal | 80 | 3% | 0% | 49 |
10 | Genetics & Heredity | 78 | 4% | 0% | 75 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | TUMOR BIOCHEM | 196215 | 2% | 28% | 41 |
2 | CANC S | 171299 | 3% | 18% | 54 |
3 | SC JOHNSON MED | 52483 | 1% | 23% | 13 |
4 | CANC BIOL GENET | 45987 | 3% | 6% | 46 |
5 | U456 | 25996 | 1% | 12% | 13 |
6 | NZ EYE | 23195 | 0% | 67% | 2 |
7 | REFERENCE MALAD INFLAMMATOI FOIE VO | 23195 | 0% | 67% | 2 |
8 | WALTHER ONCOL WALTHER CANC | 22365 | 0% | 43% | 3 |
9 | BILL WALSH CANC S | 19562 | 0% | 19% | 6 |
10 | FISIOL EXPT | 19399 | 1% | 9% | 12 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | DRUG METABOLISM AND DISPOSITION | 7454 | 3% | 1% | 57 |
2 | MOLECULAR PHARMACOLOGY | 3871 | 3% | 0% | 47 |
3 | PHARMACOGENETICS AND GENOMICS | 3425 | 1% | 1% | 15 |
4 | BIOCHEMICAL PHARMACOLOGY | 2872 | 3% | 0% | 56 |
5 | DRUG METABOLISM AND PHARMACOKINETICS | 1937 | 1% | 1% | 9 |
6 | PHARMACOGENOMICS JOURNAL | 1768 | 1% | 1% | 9 |
7 | DRUG METABOLISM REVIEWS | 1400 | 1% | 1% | 9 |
8 | BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES | 1312 | 1% | 0% | 22 |
9 | CANCER RESEARCH | 1217 | 3% | 0% | 54 |
10 | PHARMACEUTICAL RESEARCH | 1212 | 1% | 0% | 24 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | MRP1 | 675495 | 6% | 35% | 112 | Search MRP1 | Search MRP1 |
2 | MULTIDRUG RESISTANCE ASSOCIATED PROTEIN | 463863 | 5% | 30% | 89 | Search MULTIDRUG+RESISTANCE+ASSOCIATED+PROTEIN | Search MULTIDRUG+RESISTANCE+ASSOCIATED+PROTEIN |
3 | MULTIDRUG RESISTANCE PROTEIN | 421343 | 4% | 34% | 72 | Search MULTIDRUG+RESISTANCE+PROTEIN | Search MULTIDRUG+RESISTANCE+PROTEIN |
4 | MRP | 312027 | 5% | 19% | 93 | Search MRP | Search MRP |
5 | MRP2 | 278815 | 4% | 24% | 67 | Search MRP2 | Search MRP2 |
6 | DUBIN JOHNSON SYNDROME | 258805 | 2% | 55% | 27 | Search DUBIN+JOHNSON+SYNDROME | Search DUBIN+JOHNSON+SYNDROME |
7 | MRP4 | 164716 | 1% | 38% | 25 | Search MRP4 | Search MRP4 |
8 | ABCC2 | 157608 | 2% | 28% | 32 | Search ABCC2 | Search ABCC2 |
9 | GS X PUMP | 154736 | 1% | 68% | 13 | Search GS+X+PUMP | Search GS+X+PUMP |
10 | CMOAT | 153562 | 1% | 55% | 16 | Search CMOAT | Search CMOAT |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | DEELEY, RG , WESTLAKE, C , COLE, SPC , (2006) TRANSMEMBRANE TRANSPORT OF ENDO- AND XENOBIOTICS BY MAMMALIAN ATP-BINDING CASSETTE MULTIDRUG RESISTANCE PROTEINS.PHYSIOLOGICAL REVIEWS. VOL. 86. ISSUE 3. P. 849-899 | 297 | 54% | 393 |
2 | HAIMEUR, A , CONSEIL, G , DEELEY, RG , COLE, SPC , (2004) THE MRP-RELATED AND BCRP/ABCG2 MULTIDRUG RESISTANCE PROTEINS: BIOLOGY, SUBSTRATE SPECIFICITY AND REGULATION.CURRENT DRUG METABOLISM. VOL. 5. ISSUE 1. P. 21-53 | 260 | 64% | 331 |
3 | HE, SM , LI, R , KANWAR, JR , ZHOU, SF , (2011) STRUCTURAL AND FUNCTIONAL PROPERTIES OF HUMAN MULTIDRUG RESISTANCE PROTEIN 1 (MRP1/ABCC1).CURRENT MEDICINAL CHEMISTRY. VOL. 18. ISSUE 3. P. 439 -481 | 268 | 61% | 42 |
4 | ZHOU, SF , WANG, LL , DI, YM , XUE, CC , DUAN, W , LI, CG , LI, Y , (2008) SUBSTRATES AND INHIBITORS OF HUMAN MULTIDRUG RESISTANCE ASSOCIATED PROTEINS AND THE IMPLICATIONS IN DRUG DEVELOPMENT.CURRENT MEDICINAL CHEMISTRY. VOL. 15. ISSUE 20. P. 1981-2039 | 233 | 51% | 169 |
5 | CHEN, ZS , TIWARI, AK , (2011) MULTIDRUG RESISTANCE PROTEINS (MRPS/ABCCS) IN CANCER CHEMOTHERAPY AND GENETIC DISEASES.FEBS JOURNAL. VOL. 278. ISSUE 18. P. 3226 -3245 | 142 | 76% | 84 |
6 | BAKOS, E , HOMOLYA, L , (2007) PORTRAIT OF MULTIFACETED TRANSPORTER, THE MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 1 (MRP1/ABCC1).PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY. VOL. 453. ISSUE 5. P. 621-641 | 142 | 78% | 80 |
7 | KRUH, GD , BELINSKY, MG , (2003) THE MRP FAMILY OF DRUG EFFLUX PUMPS.ONCOGENE. VOL. 22. ISSUE 47. P. 7537-7552 | 131 | 72% | 389 |
8 | SODANI, K , PATEL, A , KATHAWALA, RJ , CHEN, ZS , (2012) MULTIDRUG RESISTANCE ASSOCIATED PROTEINS IN MULTIDRUG RESISTANCE.CHINESE JOURNAL OF CANCER. VOL. 31. ISSUE 2. P. 58-72 | 131 | 72% | 22 |
9 | CHANG, XB , (2007) A MOLECULAR UNDERSTANDING OF ATP-DEPENDENT SOLUTE TRANSPORT BY MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN MRP1.CANCER AND METASTASIS REVIEWS. VOL. 26. ISSUE 1. P. 15-37 | 151 | 61% | 32 |
10 | TIAN, Q , ZHANG, J , CHAN, E , DUAN, W , ZHOU, SF , (2005) MULTIDRUG RESISTANCE PROTEINS (MRPS) AND IMPLICATION IN DRUG DEVELOPMENT.DRUG DEVELOPMENT RESEARCH. VOL. 64. ISSUE 1. P. 1 -18 | 134 | 72% | 12 |
Classes with closest relation at Level 1 |